QGEN

#958
QIAGEN N.V.
41.89 USD
-0.10%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
41.84
42.00
Intervallo Annuale
38.80
57.82
Variazione giornaliera
-0.10%
Variazione Mensile
+1.75%
Variazione di 6 mesi
-11.72%
Variazione Annuale
-0.59%
Chiusura Precedente
41.93
Apertura
42.00
Bid
Ask
Minimo
41.84
High
42.00
Volume
347
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 9.09 B
  • Employee 5 654
  • Founded 1984
  • CEO Thierry Bernard
  • Website www.qiagen.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
23.18
Rapporto prezzo/fatturato
4.79
Dividendi per azione
0.25
Rendimento da dividendi %
0.56

Qiagen N.V

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.

Notizie